These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6544184)

  • 21. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway.
    Hiramatsu M; Tsokos GC
    Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis.
    Kusunoki Y; Itami N; Tochimaru H; Takekoshi Y; Nagasawa S; Yoshiki T
    Nephron; 1989; 51(1):17-9. PubMed ID: 2644563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies.
    Matsuda J; Gohchi K; Gotoh M; Tsukamoto M; Saitoh N
    Ann Hematol; 1994 Dec; 69(6):311-5. PubMed ID: 7993940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM; Colomb MG
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of serum free light chains as a marker of systemic lupus flare.
    Rodríguez-Cambrón AB; Jiménez-Jiménez J; Blázquez-Cañamero MÁ; Pazos FR; Macía-Villa C; Alcalde-Villar M; Collado-Ramos P; Del Pozo FMC; Álvarez-Andrés E; Cruz-Valenciano A
    Clin Rheumatol; 2020 Feb; 39(2):449-454. PubMed ID: 31773496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway.
    Bergamaschini L; Miedico A; Cicardi M; Coppola R; Faioni EN; Agostoni A
    Clin Exp Immunol; 1999 May; 116(2):220-4. PubMed ID: 10337010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.
    Birmingham DJ; Irshaid F; Nagaraja HN; Zou X; Tsao BP; Wu H; Yu CY; Hebert LA; Rovin BH
    Lupus; 2010 Oct; 19(11):1272-80. PubMed ID: 20605879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia.
    Buyon JP; Cronstein BN; Morris M; Tanner M; Weissmann G
    Am J Med; 1986 Aug; 81(2):194-200. PubMed ID: 3740078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
    Kerr LD; Adelsberg BR; Schulman P; Spiera H
    Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
    Carlo JR; Rothfield NF; Ruddy S
    Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C4 binding protein deficiency in a patient with atypical Behçet's disease.
    Trapp RG; Fletcher M; Forristal J; West CD
    J Rheumatol; 1987 Feb; 14(1):135-8. PubMed ID: 3572915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.